This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.
More Standards PDF
CIE x050-PO143
$19.00 $38.00
CIE x050-PP016
$19.00 $38.00
CIE x050-PO008
$19.00 $38.00
CIE x050-OP065
$19.00 $38.00









